Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hannah S.J. Choi"'
Publikováno v:
Hepatology Communications, Vol 6, Iss 5, Pp 935-949 (2022)
Chronic hepatitis B virus (HBV) infection remains difficult to cure due to the persistent, self‐replenishing nature of the viral genome and impaired host immune responses. Current treatment goals for chronic hepatitis B (CHB) are to prevent or sign
Externí odkaz:
https://doaj.org/article/b2e5ec56e9e0496b99eba1d426fb373b
Autor:
Laurens A. van Kleef, Hannah S.J. Choi, Willem P. Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld
Publikováno v:
JHEP Reports, Vol 3, Iss 5, Pp 100350- (2021)
Background & Aims: A recent consensus document has defined metabolic dysfunction-associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight, diabetes, and/or a combination of other metabolic risk factors. The clinical releva
Externí odkaz:
https://doaj.org/article/608f7207c79146e982662214621c9049
Autor:
Hannah S.J. Choi, Grishma Hirode, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Stijn Van Hees, Margarita Papatheodoridi, Sabela Lens, Grace L.H. Wong, Sylvia M. Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Milan J. Sonneveld, Henry L.Y. Chan, Xavier Forns, George V. Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Yao-Chun Hsu, Jia-Horng Kao, Markus Cornberg, Bettina E. Hansen, Wen-Juei Jeng, Harry L.A. Janssen
Publikováno v:
Clinical Gastroenterology and Hepatology, 21(6), 1513-1522.e4. W.B. Saunders
Clinical gastroenterology and hepatology
Clinical gastroenterology and hepatology
Background and Aims: Whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) differentially affect relapse and outcomes following treatment discontinuation across different patient subpopulations remains unclear. We aimed to compare rates of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14c0bfd92d44867775a3dde99dd1ce6
https://pure.eur.nl/en/publications/f6ab2987-e825-47b8-ae7f-75335165225b
https://pure.eur.nl/en/publications/f6ab2987-e825-47b8-ae7f-75335165225b
Autor:
Lesley A. Patmore, Warshan K. Katwaroe, Daniel van der Spek, Hannah S.J. Choi, Keyur Patel, Sylvia Brakenhoff, Adriaan J. van der Meer, Willem P. Brouwer, Laurens A. van Kleef, Rob J. de Knegt, Bettina E. Hansen, Rob A. de Man, Jordan J. Feld, Harry L.A. Janssen, Milan J. Sonneveld
Publikováno v:
Clinical Gastroenterology and Hepatology. W.B. Saunders
Background & Aims: Patients with chronic hepatitis B (CHB) are at increased risk of hepatocellular carcinoma and (liver-related) mortality. In addition to hepatitis B–related factors, metabolic comorbidities may contribute to the progression of fib
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection
Autor:
Willem P. Brouwer, Robert A. de Man, Harry L.A. Janssen, Sylvia M. Brakenhoff, Hannah S.J. Choi, Adam J. Gehring, Grishma Hirode, Milan J Sonneveld, Bettina E. Hansen, Mina S. Farag
Publikováno v:
Journal of Viral Hepatitis, 28(12), 1729-1737. Wiley-Blackwell Publishing Ltd
As pegylated interferon alpha (PEG-IFN-α) is increasingly used in combination regimens of novel drugs, we aimed to characterize ALT flares and their relationship with serum HBsAg and HBV RNA kinetics in a large combined cohort of chronic hepatitis B
Autor:
Grishma Hirode, Bettina Hansen, Chien-Hung Chen, Tung-Hung Su, Margarita Papatheodoridi, Sabela Lens, Stijn Van Hees, Sylvia Brakenhoff, Hannah S.J. Choi, Rong-Nan Chien, Wai-Kay Seto, Grace Wong, Jordan Feld, Henry LY Chan, Man-Fung Yuen, Milan Sonneveld, Thomas Vanwolleghem, Xavier Forns, George Papatheodoridis, Jia-Horng Kao, Yao-Chun Hsu, Markus Cornberg, Rachel Wen-Juei Jeng, Harry Janssen
Publikováno v:
Journal of Hepatology. 77:S852-S853
Publikováno v:
Hepatology communications. 6(5)
Chronic hepatitis B virus (HBV) infection remains difficult to cure due to the persistent, self-replenishing nature of the viral genome and impaired host immune responses. Current treatment goals for chronic hepatitis B (CHB) are to prevent or signif
Autor:
Harry L.A. Janssen, Laurens A. van Kleef, Bettina E. Hansen, Keyur Patel, Willem P. Brouwer, Robert A. de Man, Hannah S.J. Choi, Robert J. de Knegt, Milan J. Sonneveld
Publikováno v:
JHEP Reports, Vol 3, Iss 5, Pp 100350-(2021)
JHEP Reports
JHEP Reports, 3(5):100350. Elsevier
JHEP Reports
JHEP Reports, 3(5):100350. Elsevier
Background & Aims A recent consensus document has defined metabolic dysfunction-associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight, diabetes, and/or a combination of other metabolic risk factors. The clinical relevan
Autor:
Hannah S.J. Choi, Grishma Hirode, Chien-Hung Chen, Tung-Hung Su, Margarita Papatheodoridi, Sabela Lens, Stijn Van Hees, Sylvia Brakenhoff, Rong-Nan Chien, Wai-Kay Seto, Grace Wong, Jordan Feld, Henry Ly Chan, Man-Fung Yuen, Milan Sonneveld, Thomas Vanwolleghem, Xavier Forns, George Papatheodoridis, Jia-Horng Kao, Yao-Chun Hsu, Markus Cornberg, Bettina Hansen, Rachel Wen-Juei Jeng, Harry Janssen
Publikováno v:
Journal of Hepatology. 77:S861
Autor:
Bettina E. Hansen, Oliver Lenz, Veronica Miller, Gabriel Westman, Poonam Mishra, Ryan T. Anderson, Harry L.A. Janssen, Eric F. Donaldson, Hannah S.J. Choi, Stephanie Buchholz, Marion G. Peters
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 19(3)
Seroclearance of hepatitis B surface antigen (HBsAg) is the desired end point of treatment for chronic hepatitis B virus (HBV) infection, according to guidelines. We performed a systematic review and meta-analysis to evaluate the strength of the asso